| Damaging Effects Of Cigarette Smoke Mimicked By Newly Detected Air Pollutant |
| A previously unrecognized group of air pollutants could have effects remarkably similar to harmful substances found in tobacco smoke, Louisiana scientists are reporting in a study scheduled for presentation at the 236th National Meeting of the American Chemical Society. Inhaling those pollutants exposes the average person up to 300 times more free radicals daily than from smoking one cigarette, they added. |
| Lung Cancer Studies Earn Prestigious Award |
| Shahriyour Andaz, MD, FACS, FRCS, Director of Thoracic Oncology at South Nassau Communities Hospital, is the co-author of two studies that earned honors at the Brooklyn and Long Island Chapter of the American College of Surgeons Murry Friedman Surgical Resident Competition. |
| Despite Hazards, 1/5 Of British Adult Survivors Of Childhood Cancer Are Smokers |
| One-fifth of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, according to a study in the July 29 online issue of the Journal of the National Cancer Institute. Adult survivors of childhood cancer are at increased risk of developing cardiovascular disease, lung problems, and second malignancies, relative to the general public. |
| Anti-Tobacco Campaign Tests Lung Capacity, Determination And Tobacco Awareness In 'Miley Mania Adventure' |
| Pop culture, anti-tobacco awareness and physical endurance merged last Friday in The TRUTH's 'Miley Mania Adventure' in Salt Lake City. Twenty parent-child teams faced six anti-tobacco riddles that lead them to scavenge over 50 miles of the Wasatch Front with nothing more than their own two feet and the local public transit system. |
| Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine Or Vinorelbine In Performance Status (PS 2) NSCLC Patients |
| Cell Therapeutics, Inc. (CTI) announced the publication of results from its randomized phase III trial comparing OPAXIO(TM) (paclitaxel poliglumex, CT-2103) with gemcitabine or vinorelbine for the treatment of PS 2 (performance status 2) patients with previously untreated non-small cell lung cancer (NSCLC) in the Journal of Thoracic Oncology (Volume 3, Number 7, July 2008). Results showed that overall survival was similar between the two arms (hazard ratio of 0. |